Market
What will be the outcome of the initial human trials for the UK-developed urine test by 2026?
2
Resolution / Starting Odds
Successful with no major issues • 25%
Successful with some issues • 25%
Unsuccessful • 25%
Trials not completed • 25%
Results published by Cancer Research UK or in scientific journals
Story
UK Researchers Develop Urine Test Targeting Zombie Cell Proteins to Detect Early Lung Cancer, Addressing 230,000 Annual EU Deaths
Dec 6, 2024, 12:00 PM
Researchers in the United Kingdom have developed a groundbreaking urine test that can detect early signs of lung cancer by targeting specific proteins associated with 'zombie' cells. This innovative test aims to identify cancer months or even years before symptoms appear, potentially reducing the need for invasive treatments. The test has shown promising results in trials, with plans for human trials underway, according to Kevin Brindle from the Cancer Research UK Cambridge Centre. Lung cancer is a significant health issue, causing nearly 230,000 deaths annually in the European Union.
View original story
Similar markets
Moderately successful • 25%
Neutral • 25%
Unsuccessful • 25%
Highly successful • 25%
Neurodegenerative Diseases • 25%
Other • 25%
Cardiovascular Diseases • 25%
Cancer • 25%
Successful with expected results • 25%
Results inconclusive • 25%
Unsuccessful • 25%
Partially successful • 25%
Trial not completed • 25%
Unsafe • 25%
Inconclusive • 25%
Safe and effective • 25%
Trial discontinued • 25%
Positive results with MRD-negative CR • 25%
Mixed results • 25%
Negative results • 25%
No • 50%
Yes • 50%
Negative outcome • 25%
Positive outcome • 25%
Inconclusive • 25%
Trial not completed • 25%
